Each filer's latest filing for 59045L205 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
| Vanguard Group Inc 13G/A | 4.2% |
1/30/2026
Event 12/31/2025
|
||
|
683 Capital Management, LLC
13G/A
|
0% |
5/15/2026
Event 3/31/2026
|
||
| 683 Capital Management, LLC | 0% | |||
| 683 Capital Partners, LP | 0% | |||
| Ari Zweiman | 0% | |||
|
Bain Capital Life Sciences Fund II, L.P.
13D/A
|
0% |
1/8/2026
Event 1/6/2026
|
||
| Bain Capital Life Sciences Fund II, L.P. | 0% | |||
| BCIP Life Sciences Associates, LP | 0% | |||
| BCLS II Investco, LP | 0% | |||
|
Nextech Crossover I GP S.a r.l.
13G/A
|
0% |
1/9/2026
Event 1/6/2026
|
||
| Nextech Crossover I GP S.a. r.l. | 0% | |||
| Nextech Crossover I SCSp | 0% | |||
| Ian Charoub | 0% | |||
| Costas Constantinides | 0% | |||
| Rocco Sgobbo | 0% | |||